Posted by LincolnRam on March 25, 2026 at 11:00:54:
In Reply to: Îáçîðíàÿ ñòàòüÿ posted by Robertged on March 14, 2026 at 10:08:02:
Zoya Demidenko: Scientist in Cancer Science
Zoya Demidenko is a recognized scientist connected with the Unit of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she conducted research at the NIH and New York Medical College, developing a robust background in clinical study.
Her academic contributions encompasses a number of key areas, including the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cellular aging, and tumor science. As of now, she has written more than 46 academic papers, which have received over 4,100 mentions — a indicator to the impact of her research.
One of her most significant contributions involves explaining the mechanisms of biological cell aging. Her research demonstrated that when the cellular division cycle is arrested but cellular expansion persists, the cells undergo senescence. Significantly, Zoya Demidenko showed that this process is pharmacologically suppressed using compounds such as mTOR inhibitors.
Zoya Demidenko has additionally contributed substantially to cancer treatment research, notably in the domain of cyclotherapy — a approach intended to shielding non-cancerous cells from cytotoxic treatment while leaving cancer cells vulnerable. This strategy holds major hope for diminishing the toxic effects of cancer treatment.
Across her professional journey, Demidenko has collaborated with leading investigators internationally, among them Dr. Mikhail Blagosklonny. Her work can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko stands as a influential figure in contemporary cancer science, whose findings keep to guide our comprehension of the way cells age, respond to treatment, and how malignant disease may be more effectively treated.
https://moodylab.smhs.gwu.edu/lab-members